Showing results (31-40 of 121) with videos related to

Sort By:
Pageof 13
BMJ Open|February 6, 2025
Results of a modified Delphi consensus on the optimal testing pathway for oesophago-gastric cancer care in the UKManuel Rodriguez-Justo, Wasat Mansoor, Thomas Bird, et al.
BMC Cancer|July 10, 2008
Gemcitabine based combination chemotherapy in advanced pancreatic cancer-indirect comparisonAsma Sultana, Paula Ghaneh, David Cunningham, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 20, 2007
Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancerAsma Sultana, Catrin Tudur Smith, David Cunningham, et al.
Therapeutic Advances in Medical Oncology|January 25, 2021
Modification of systemic anti-cancer therapies and weight loss, a population-level real-world evidence studyClare Shaw, Naureen Starling, Adam Reich, et al.
World Journal of Gastrointestinal Oncology|September 5, 2017
Impact of tumour histological subtype on chemotherapy outcome in advanced oesophageal cancerMichael Davidson, Ian Chau, David Cunningham, et al.
Critical Reviews in Oncology/Hematology|November 4, 2019
Targeting EGFR pathway in metastatic colorectal cancer- tumour heterogeniety and convergent evolutionKhurum Khan, Nicola Valeri, Charles Dearman, et al.
Lancet (London, England)|March 23, 2010
Colorectal cancerDavid Cunningham, Wendy Atkin, Heinz-Josef Lenz, et al.
Future Science OA|July 9, 2025
The prognostic impact of human epidermal growth factor receptor 2 status in metastatic colorectal cancerKaren Bartley, Jeremy Snider, Cheryl Cho-Phan, et al.
Pageof 13